ASD causal genes | Region/neurons/cells in which gene function is affected | Species | Affected signaling pathway | Phenotypes/downstream targets | Citations |
---|---|---|---|---|---|
5-HT GOF (gain-of-function) | Blood | Human | TGF-β | TGF-β pathway identified as a novel hyperserotonemia-related ASD genes | [18] |
ALDH1A3 | Â | Human | RA | Â | [135] |
ANK3 LOF (loss-of-function) | P19 cells, proliferating neural progenitors of E16 mouse cortices, E15 brain slices | Mouse | WNT (canonical) | Increases proliferation of neural progenitor cells and nuclear β-catenin | [85] |
APC LOF | Forebrain neurons, and hippocampal, cortical, and striatal regions | Mouse | WNT (canonical) | Learning and memory impairments and autistic-like behaviors (increased repetitive behaviors, reduced social interest) | [1] |
BTBR T+ Itpr3tf/J (BTBR) mice | Spleen and brain tissues | Mouse | TGF-β | Decreased TGF-β levels | [17] |
CD38 | Lymphoblastoid cell lines | Human and mouse | RA | Upregulation of CD38 by RA | |
CHD8−/− LOF | Whole | Mouse | WNT (canonical) | Embryonically lethal | [87] |
CHD8+/− LOF | Nucleus accumbens (NAc) | Mouse | WNT (canonical) | Macrocephaly, craniofacial abnormalities, and behavioral deficits; WNT signaling upregulates in the nucleus accumbens (NAc) region of the brain | [89] |
CTNNB1 LOF | Parvalbumin interneurons | Mouse | WNT (canonical) | Impaired object recognition and social interactions; elevated repetitive behaviors; enhanced spatial memory | [66] |
CTNNB1 cKO LOF | Dorsal neural folds | Mouse | WNT (canonical) | Spina bifida aperta, caudal axis bending, and tail truncation | [65] |
CTNNB1 haploinsufficiency LOF | Whole | Human and mouse | WNT (canonical) | Neuronal loss, craniofacial anomalies, and hair follicle defects | [64] |
DHCR7 LOF | MEFs | Mouse | SHH | Impaired SMO and reduced SHH signaling | [111] |
DIXDC1 LOF | Mouse cortex | Human and mouse | WNT (canonical) | Impaired dendrite and spine growth, positive modulator of WNT signaling | [79] |
Dlx5 GOF | 2B1 cell line | Mouse | BMP | Upregulation of BMP binding endothelial regulator (Bmper) | [13] |
DNlg4 LOF | NMJ | Drosophila | BMP | Reduced growth of neuromuscular junctions (NMJs) with fewer synaptic boutons | [10] |
EN2 GOF | Post-mortem samples | Human | SHH | Elevated SHH expression | [117] |
FGF22/FGF7 LOF | Hippocampal CA3 pyramidal neurons | Mouse | FGF | Impaired synapse formation | [124] |
FMRP depletion | COS-7 cells | Monkey | BMP | Increase in BMPR2 and activation of LIMK1, stimulates reorganization of actin to promote neurite outgrowth and synapse formation | [11] |
FOXN1 | Â | Human | RA | Â | [135] |
mGluR5 LOF | Cortical neurons | Mouse | FGF | Increased NGF and FGF10 mRNA levels | [125] |
PGE2 | Differentiating neuronal cells | Humans | WNT (canonical) | Upregulation of WNT3 and TCF4 | |
PRICKLE2 LOF | Hippocampal neurons | Mouse | WNT (non-canonical) | Altered social interaction, learning abnormalities, and behavioral inflexibility | [40] |
PTCHD1 LOF | Dentate gyrus | Mouse | SHH (hypothetical) | SHH independent; disrupted synaptic transmission | [109] |
RERE | Â | Human | RA | Â | [137] |
RORA LOF | Lymphoblastoid cell lines | Human | RA | Reduced protein levels of RORA and BCL-2 in autistic brain; aberrant methylation | [133] |
TCF7L2 LOF | Â | Human and mouse | WNT (canonical) | Required for thalamocortical axonal projection formation | |
UBE3A GOF | Prefrontal cortex | Mouse | RA | Negative regulation of ALDH1A2; impaired RA-mediated synaptic plasticity | [139] |
ube3a LOF | NMJ | Drosophila | BMP | Compromised endocytosis in the NMJs and an upregulated BMP signaling in the nervous system | [12] |
UBE3AT485A LOF | HEK293T cells | Human | WNT (canonical) | Stabilizes nuclear β-catenin and stimulates canonical WNT signaling | [78] |
WNT1, WNT2, WNT3, WNT9B | Â | Human | WNT (canonical) | Elevated WNT3 expression in the prefrontal cortex of ASD patients |